|
Immunotherapy (nivolumab and relatlimab) Clinical Trials
1 actively recruiting trial across 1 location
Newport Beach, California1 trial
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
USC Newport Beach
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.